119 related articles for article (PubMed ID: 12518028)
1. The effects of protease inhibitors on basal and insulin-stimulated lipid metabolism, insulin binding, and signaling.
Cammalleri C; Germinario RJ
J Lipid Res; 2003 Jan; 44(1):103-8. PubMed ID: 12518028
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
Schütt M; Zhou J; Meier M; Klein HH
J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
[TBL] [Abstract][Full Text] [Related]
3. HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.
Lenhard JM; Furfine ES; Jain RG; Ittoop O; Orband-Miller LA; Blanchard SG; Paulik MA; Weiel JE
Antiviral Res; 2000 Aug; 47(2):121-9. PubMed ID: 10996400
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence early insulin signaling.
Algenstaedt P; Daneshi S; Schwarzloh B; Hennigs N; Hamann A; Hansen-Algenstaedt N; Beisiegel U
Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):491-8. PubMed ID: 14714271
[TBL] [Abstract][Full Text] [Related]
5. Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors.
Ben-Romano R; Rudich A; Török D; Vanounou S; Riesenberg K; Schlaeffer F; Klip A; Bashan N
AIDS; 2003 Jan; 17(1):23-32. PubMed ID: 12478066
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
Vernochet C; Azoulay S; Duval D; Guedj R; Ailhaud G; Dani C
AIDS; 2003 Oct; 17(15):2177-80. PubMed ID: 14523274
[TBL] [Abstract][Full Text] [Related]
7. The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes.
Ranganathan S; Kern PA
J Endocrinol; 2002 Jan; 172(1):155-62. PubMed ID: 11786383
[TBL] [Abstract][Full Text] [Related]
8. Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes.
Janneh O; Hoggard PG; Tjia JF; Jones SP; Khoo SH; Maher B; Back DJ; Pirmohamed M
Antivir Ther; 2003 Oct; 8(5):417-26. PubMed ID: 14640389
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases.
Mondal D; Larussa VF; Agrawal KC
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1569-84. PubMed ID: 11779345
[TBL] [Abstract][Full Text] [Related]
10. Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis.
Adler-Wailes DC; Liu H; Ahmad F; Feng N; Londos C; Manganiello V; Yanovski JA
J Clin Endocrinol Metab; 2005 Jun; 90(6):3251-61. PubMed ID: 15741249
[TBL] [Abstract][Full Text] [Related]
11. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes.
Inaba T; Fischer NE; Riddick DS; Stewart DJ; Hidaka T
Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958
[TBL] [Abstract][Full Text] [Related]
12. Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro.
Hoggard PG; Manion V; Barry MG; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):164-7. PubMed ID: 9491831
[TBL] [Abstract][Full Text] [Related]
13. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
Jones SP; Janneh O; Back DJ; Pirmohamed M
Antivir Ther; 2005; 10(2):207-13. PubMed ID: 15865214
[TBL] [Abstract][Full Text] [Related]
14. The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes.
Rudich A; Vanounou S; Riesenberg K; Porat M; Tirosh A; Harman-Boehm I; Greenberg AS; Schlaeffer F; Bashan N
Diabetes; 2001 Jun; 50(6):1425-31. PubMed ID: 11375344
[TBL] [Abstract][Full Text] [Related]
15. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
Sakoda H; Ogihara T; Anai M; Funaki M; Inukai K; Katagiri H; Fukushima Y; Onishi Y; Ono H; Fujishiro M; Kikuchi M; Oka Y; Asano T
Diabetes; 2000 Oct; 49(10):1700-8. PubMed ID: 11016454
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes.
Burén J; Liu HX; Jensen J; Eriksson JW
Eur J Endocrinol; 2002 Mar; 146(3):419-29. PubMed ID: 11888850
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.
Eagling VA; Back DJ; Barry MG
Br J Clin Pharmacol; 1997 Aug; 44(2):190-4. PubMed ID: 9278209
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
[TBL] [Abstract][Full Text] [Related]
20. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
